3CT 2024 – Critical Care Clinical Trialists Workshop

Contact Info

Neuendorfstraße 15A
Hennigsdorf b. Berlin
D-16761, Germany.

By loading the map, you agree to Google's privacy policy.
Learn more

Always unblock Google Maps

PGlmcmFtZSBsb2FkaW5nPSJsYXp5IgoJCQkJCXNyYz0iaHR0cHM6Ly9tYXBzLmdvb2dsZS5jb20vbWFwcz9xPU5ldWVuZG9yZnN0cmElQzMlOUZlJTIwMTVBJTJDJTIwMTY3NjElMjBIZW5uaWdzZG9yZiYjMDM4O3Q9bSYjMDM4O3o9MTUmIzAzODtvdXRwdXQ9ZW1iZWQmIzAzODtpd2xvYz1uZWFyIgoJCQkJCXRpdGxlPSJOZXVlbmRvcmZzdHJhw59lIDE1QSwgMTY3NjEgSGVubmlnc2RvcmYiCgkJCQkJYXJpYS1sYWJlbD0iTmV1ZW5kb3Jmc3RyYcOfZSAxNUEsIDE2NzYxIEhlbm5pZ3Nkb3JmIgoJCQk+PC9pZnJhbWU+

3CT 2024 – Critical Care Clinical Trialists Workshop

Recent News

AdrenoMed Receives FDA Fast Track Designation for Enibarcimab for Treatment of Septic Shock

Adrenomed to attend San Francisco industry and investor conferences

Adrenomed presents new findings on its precision medicine treatment for septic shock with enibarcimab during Weimar Sepsis Update

Adrenomed appoints Dr. Stephan Witte as Chief Medical Officer

Adrenomed to attend upcoming industry and investor conferences

Adrenomed appoints David Germonpré as Chief Financial Officer

Media Coverage

Join the fight against sepsis – invest in life-saving precision medicine at capitalcell.com.

Article in The Lancet: On the front lines of the sepsis crisis: hurdles faced by sepsis researchers, survivors, and family advocates

Article in InVivo: End Game: Adrenomed Targets Global Reach For Sepsis Candidate

Article in MedNous: Adrenomed prepares global study in septic shock

Article on LaBiotech: Watch: Adrenomed tackling huge issue of sepsis

Article in GoingPublic’s Plattform Life Sciences: “A phenomenal breakthrough is taking shape”

Recent Events

J.P. Morgan Week & Biotech Showcase 2025 – Meet us in San Francisco

2024 World Sepsis Day Symposium